Company & Sponsor Intelligence
Johns Hopkins Bloomberg School of Public Health
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed3
Countries1
Therapeutic footprint
adhdalzheimersschizophrenia
Indexed studies
NCT03136692Analysis of De-identified Data From Commercially-available App Lose It!
alzheimers · COMPLETED
alzheimers · COMPLETED
NCT00312949Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia
schizophrenia · United StatesNA
schizophrenia · United StatesNA
NCT00149812A Clinic-based Prevention Program for Families of Depressed Mothers
adhd · United StatesPHASE1
adhd · United StatesPHASE1
Intelligence layer updated: 2026-10-16 06:15:38.640633+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →